MedTrace Logo

Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura

NCT00126035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2005-08-17

No results posted yet for this study

Summary

The purpose of the study was to assess the efficacy of Migraid in terms of preventing headaches in patients with migraine with typical aura. The secondary objectives were to assess whether Migraid is able to achieve pain relief and/or relief of migraine associated symptoms and to evaluate the safety and tolerability of the study treatment.

Conditions

  • Migraine With Typical Aura

Interventions

DEVICE

Migraid

Sponsors & Collaborators

  • Profess Medical Consultancy

    lead OTHER

Principal Investigators

  • Joop AM Kuster, MD · Kennemer Gasthuis Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2004-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126035 on ClinicalTrials.gov